Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Clark

Showing results (511-520 of 888) with videos related to

Pageof 89
Sort By:
Cytokine|September 1, 1991
Antibodies to interleukin 3 as probes for the interaction of interleukin 3 with its receptorV Duronio, S R Granleese, I Clark-Lewis, et al.
JAMA|March 27, 1991
Exposing patients with chronic, stable, exertional angina to placebo periods in drug trialsS P Glasser, P I Clark, R J Lipicky, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosisLauren A Shreve, Cathal O'Leary, Timothy W I Clark, et al.
The British Journal of Ophthalmology|January 30, 1999
Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laserI A Pearce, F C Pennie, L M Gannon, et al.
Health & Place|September 8, 2009
Key stakeholder perspectives on the development of walkable neighbourhoodsMarianne I Clark, Tanya R Berry, John C Spence, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 22, 2005
Methods to assess potential reduced exposure productsDorothy K Hatsukami, Gary A Giovino, Thomas Eissenberg, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 10, 2002
Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulasDheeraj K Rajan, Timothy W I Clark, Martin E Simons, et al.
The Journal of Biological Chemistry|June 10, 2000
NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor bindingE L Elisseeva, C M Slupsky, M P Crump, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3H J Ziltener, I Clark-Lewis, L E Hood, et al.
Pageof 89

Showing results (511-520 of 888) with videos related to

Sort By:
Pageof 89
Cytokine|September 1, 1991
Antibodies to interleukin 3 as probes for the interaction of interleukin 3 with its receptorV Duronio, S R Granleese, I Clark-Lewis, et al.
JAMA|March 27, 1991
Exposing patients with chronic, stable, exertional angina to placebo periods in drug trialsS P Glasser, P I Clark, R J Lipicky, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosisLauren A Shreve, Cathal O'Leary, Timothy W I Clark, et al.
The British Journal of Ophthalmology|January 30, 1999
Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laserI A Pearce, F C Pennie, L M Gannon, et al.
Health & Place|September 8, 2009
Key stakeholder perspectives on the development of walkable neighbourhoodsMarianne I Clark, Tanya R Berry, John C Spence, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 22, 2005
Methods to assess potential reduced exposure productsDorothy K Hatsukami, Gary A Giovino, Thomas Eissenberg, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 10, 2002
Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulasDheeraj K Rajan, Timothy W I Clark, Martin E Simons, et al.
The Journal of Biological Chemistry|June 10, 2000
NMR studies of active N-terminal peptides of stromal cell-derived factor-1. Structural basis for receptor bindingE L Elisseeva, C M Slupsky, M P Crump, et al.
Medical Oncology (Northwood, London, England)|December 26, 2012
Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancerJoseph I Clark, Joshua B Greene, Ann Lau Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3H J Ziltener, I Clark-Lewis, L E Hood, et al.
Pageof 89